Blog

Careers

Advertise

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2022
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2022
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News

HSCA Applauds Senators Collins and Smith for Bipartisan Legislation to Prevent and Mitigate Drug Shortages

October 30, 2019 by Brigid Hasson Uncategorized 0 comments

Washington, DC (October 30, 2019) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement applauding Senator Susan Collins (R-ME) and Senator Tina Smith (D-MN) and announcing HSCA’s support for The Mitigating Emergency Drug Shortages (MEDS) Act:

“HSCA and its member group purchasing organizations (GPOs) applaud Senators Collins and Smith for their bipartisan leadership in addressing drug shortages, reducing healthcare costs, and improving patient outcomes for Americans across the country. HSCA strongly supports the MEDS Act, which builds upon the important steps Congress has taken to provide additional authority to the FDA to help mitigate drug shortages and develop market-based incentives to ensure a stable supply of medications critical for patient care.

Click here to read the full statement.

Prev
Next

Related Posts

Joint Letter of Support for the MEDS Act
November 5, 2019

Dear Senator Collins and Senator Smith, The undersigned organizations are...

Learn more
HSCA RELEASES HEALTHCARE CYBERSECURITY KEY CONSIDERATIONS TO HELP PROTECT PATIENT HEALTH, SAFETY, AND PRIVACY
December 21, 2021

Washington, DC (December 21, 2021) – The Healthcare Supply Chain Association...

Learn more
HSCA Applauds Senators Collins and Smith for Bipartisan Legislation to Prevent and Mitigate Drug Shortages
October 30, 2019

Washington, DC (October 30, 2019) – Healthcare Supply Chain Association (HSCA)...

Learn more
HSCA Comments to the Senate Committee on Health, Education, Labor, and Pensions on the PREVENT Pandemics Act
April 1, 2022

On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...

Learn more

Our Office

Healthcare Supply Chain Association
1341 G Street NW Suite 600
Washington, DC 20005

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • HSCA Support Letter to the House Committee on Energy & Commerce on House Passage of FDA User Fee Reauthorizations
    June 30, 2022
  • ANALYSIS: GPOs Helped Increase Domestic Manufacturing Capacity, Protected Hospitals and Patients from Thousands of Fraudulent Sellers, and Helped Identify and Bring New Suppliers to Market to Avert Supply and Drug Shortages During COVID-19
    April 20, 2022